This inventor holds 2 USPTO granted patents. Top assignee: National Yang Ming Chiao Tung University. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Innovations of Ching-Cheng Chuang in Alzheimer's Disease Treatment
Introduction
Ching-Cheng Chuang is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of medical technology, particularly in the treatment and early screening of Alzheimer's disease. With a total of two patents to his name, his work is paving the way for innovative solutions in healthcare.
Latest Patents
Chuang's latest patents include an electrochemical dephosphorylation technique for treating Alzheimer's disease and color-changing eye drops for early screening of the disease. The first patent involves a gold electrode that operates at a negative potential of -0.2 V to -0.6 V, aimed at addressing the challenges posed by Alzheimer's. The second patent focuses on color-changing eye drops that utilize Aβaptamer-gold nanoparticles (AuNPs) mixed with a tear sample to analyze color changes, which can help determine the concentration of Aβ in the sample.
Career Highlights
Ching-Cheng Chuang is affiliated with National Yang Ming Chiao Tung University, where he continues to engage in research and development. His work is characterized by a strong emphasis on practical applications that can lead to improved diagnostic and therapeutic options for Alzheimer's disease.
Collaborations
Chuang collaborates with esteemed colleagues, including Jung-Chih Chen and I-Chiu Li, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their innovations in the medical field.
Conclusion
Ching-Cheng Chuang's innovative patents represent a significant advancement in the fight against Alzheimer's disease. His dedication to research and collaboration underscores the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile